There’s been a recent change in the hypertension guidelines. Recommendations from AHA/ACC have been made to get a little more aggressive with hypertension management compared to JNC-8. I outline some of the important differences in the presentation below. I...
There are a lot of examples that fit this criteria and I suspect a lot of heavy opinions on this topic. I’ve certainly made suggestions to switch to a likely “safer” medication, but have had instances where I disagree with this practice as well in...
I will be heading on my way back to Minnesota tomorrow, so this will be the last ASHP Midyear post. Hope you all enjoyed it, and maybe I will head back next year…we’ll see! Day 4 of ASHP Midyear took on a medication safety theme. I took part in a pain...
Day 3 at ASHP 2017 has been a little more depressing due to the pharmacist job market. I’ve been speaking to quite a few residents and students, and I seem to leave those conversations with pessimism. The pharmacist job market feels bad. Many students,...
I’m a little late on my day 2 wrap up of the ASHP Midyear meeting. With ongoing discussions today with more pharmacists, residents and students, I can’t help but think what pharmacy is going to look like in 10 or 20 years. I think the key to identifying...
